- Tytuł:
- A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 study
- Autorzy:
- Źródło:
- Cancer Immunology, Immunotherapy. 72(4):827-840
Czasopismo naukowe